Usana Health Sciences (USNA) Amortization of Deferred Charges (2019 - 2021)

Usana Health Sciences (USNA) has 3 years of Amortization of Deferred Charges data on file, last reported at $2.2 million in Q4 2021.

• Amortization of Deferred Charges for Q4 2021 came in at $2.2 million, up 5.51% year-over-year; the trailing twelve-month figure through Oct 2021 was $9.1 million (up 4.78% YoY), and the FY2021 annual result was $8.8 million, up 6.03% from the prior year.
• Amortization of Deferred Charges slipped to $2.2 million in Q4 2021 per USNA's latest filing, from $2.3 million in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $2.3 million in Q1 2021 and troughed at $2.0 million in Q2 2019.
• A 3-year average of $2.2 million and a median of $2.2 million in 2019 frame the typical range for Amortization of Deferred Charges.
• The sharpest annual moves came in 2020 and 2021: Amortization of Deferred Charges grew 11.47% in 2020, then rose 0.18% in 2021.
• A 3-year view of Amortization of Deferred Charges shows it stood at $2.2 million in 2019, then decreased by 2.07% to $2.1 million in 2020, then climbed by 5.51% to $2.2 million in 2021.
• Business Quant data shows USNA's Amortization of Deferred Charges at $2.2 million in Q4 2021, $2.3 million in Q3 2021, and $2.3 million in Q2 2021.